385 related articles for article (PubMed ID: 11971192)
1. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).
Todd JL; Rigas JD; Rafty LA; Denu JM
Oncogene; 2002 Apr; 21(16):2573-83. PubMed ID: 11971192
[TBL] [Abstract][Full Text] [Related]
2. Extracellular regulated kinases (ERK) 1 and ERK2 are authentic substrates for the dual-specificity protein-tyrosine phosphatase VHR. A novel role in down-regulating the ERK pathway.
Todd JL; Tanner KG; Denu JM
J Biol Chem; 1999 May; 274(19):13271-80. PubMed ID: 10224087
[TBL] [Abstract][Full Text] [Related]
3. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
[TBL] [Abstract][Full Text] [Related]
4. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1.
Shen Y; Luche R; Wei B; Gordon ML; Diltz CD; Tonks NK
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13613-8. PubMed ID: 11717427
[TBL] [Abstract][Full Text] [Related]
6. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
Slack DN; Seternes OM; Gabrielsen M; Keyse SM
J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of VHR phosphatase by ZAP-70.
Alonso A; Rahmouni S; Williams S; van Stipdonk M; Jaroszewski L; Godzik A; Abraham RT; Schoenberger SP; Mustelin T
Nat Immunol; 2003 Jan; 4(1):44-8. PubMed ID: 12447358
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation.
Alonso A; Saxena M; Williams S; Mustelin T
J Biol Chem; 2001 Feb; 276(7):4766-71. PubMed ID: 11085983
[TBL] [Abstract][Full Text] [Related]
9. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
Durham PL; Russo AF
Mol Endocrinol; 1998 Jul; 12(7):1002-9. PubMed ID: 9658404
[TBL] [Abstract][Full Text] [Related]
10. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
[TBL] [Abstract][Full Text] [Related]
11. Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase.
Cadalbert L; Sloss CM; Cameron P; Plevin R
Cell Signal; 2005 Oct; 17(10):1254-64. PubMed ID: 16038800
[TBL] [Abstract][Full Text] [Related]
12. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases.
Muda M; Theodosiou A; Rodrigues N; Boschert U; Camps M; Gillieron C; Davies K; Ashworth A; Arkinstall S
J Biol Chem; 1996 Nov; 271(44):27205-8. PubMed ID: 8910287
[TBL] [Abstract][Full Text] [Related]
13. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
[TBL] [Abstract][Full Text] [Related]
14. Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence.
Rahmouni S; Cerignoli F; Alonso A; Tsutji T; Henkens R; Zhu C; Louis-dit-Sully C; Moutschen M; Jiang W; Mustelin T
Nat Cell Biol; 2006 May; 8(5):524-31. PubMed ID: 16604064
[TBL] [Abstract][Full Text] [Related]
15. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines.
Matsuguchi T; Musikacharoen T; Johnson TR; Kraft AS; Yoshikai Y
Mol Cell Biol; 2001 Oct; 21(20):6999-7009. PubMed ID: 11564882
[TBL] [Abstract][Full Text] [Related]
16. The JNK-interacting protein-1 scaffold protein targets MAPK phosphatase-7 to dephosphorylate JNK.
Willoughby EA; Perkins GR; Collins MK; Whitmarsh AJ
J Biol Chem; 2003 Mar; 278(12):10731-6. PubMed ID: 12524447
[TBL] [Abstract][Full Text] [Related]
17. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats.
Chung J; Chavez PR; Russell RM; Wang XD
Oncogene; 2002 Feb; 21(10):1539-47. PubMed ID: 11896582
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase.
Groom LA; Sneddon AA; Alessi DR; Dowd S; Keyse SM
EMBO J; 1996 Jul; 15(14):3621-32. PubMed ID: 8670865
[TBL] [Abstract][Full Text] [Related]
20. The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway.
Chen AJ; Zhou G; Juan T; Colicos SM; Cannon JP; Cabriera-Hansen M; Meyer CF; Jurecic R; Copeland NG; Gilbert DJ; Jenkins NA; Fletcher F; Tan TH; Belmont JW
J Biol Chem; 2002 Sep; 277(39):36592-601. PubMed ID: 12138158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
